SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Celgene International Sárl Release: Apremilast Palace Program Demonstrates Robust and Consistent Statistically Significant Clinical Benefit Across Three Pivotal Phase III Studies (PALACE-1, 2 & 3) in Psoriatic Arthritis